Leadless Cardiac Resynchronization Therapy (Crt)

FDA product code SEG · Class III (high risk) · Cardiovascular

Leadless Cardiac Resynchronization Therapy (CRT) is intended to deliver CRT using a leadless left ventricular implant

0510(k) clearances
1PMA approvals
0recalls
Implantimplanted device

PMA approvals